Precigen
Precigen
precigen.com

Locations

Germantown, MD, USA

industry

Biotechnology

Size

51 - 200 employees

Stage

IPO

founded in

2020

Precigen: Advancing Medicine with Precision™ Precigen (NASDAQ: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.


Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Israel VC Forum network.

Something looks off?
Open jobs at Precigen

On-site & Remote